3.財務諸表及び主な注記
(1)貸借対照表
| | (単位:千円) |
| 前事業年度 (2025年9月30日) | 当事業年度 (2026年9月30日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 2,170,097 | 1,423,894 |
売掛金 | 255,760 | 276,021 |
有価証券 | 1,000,000 | 1,000,000 |
仕掛品 | 21,521 | 20,630 |
原材料及び貯蔵品 | 28,228 | 26,776 |
前渡金 | 12,924 | 5,793 |
前払費用 | 85,479 | 29,478 |
その他 | 37,604 | 38,231 |
流動資産合計 | 3,611,617 | 2,820,827 |
固定資産 | | |
有形固定資産 | | |
建物(純額) | 283,465 | 451,613 |
工具、器具及び備品(純額) | 48,118 | 52,530 |
リース資産(純額) | 3,554 | 2,644 |
建設仮勘定 | 21,482 | 21,482 |
有形固定資産合計 | 356,621 | 528,271 |
無形固定資産 | | |
特許権 | 12,291 | 18,750 |
ソフトウエア | 38,434 | 37,643 |
ソフトウエア仮勘定 | 17,261 | 57,702 |
無形固定資産合計 | 67,987 | 114,096 |
投資その他の資産 | | |
投資有価証券 | 154,550 | 55,877 |
長期貸付金 | 459,250 | 423,250 |
破産更生債権等 | 23,468 | 23,468 |
長期前払費用 | 1,285 | 853 |
差入保証金 | 62,007 | 60,539 |
貸倒引当金 | △482,718 | △446,718 |
投資その他の資産合計 | 217,843 | 117,269 |
固定資産合計 | 642,452 | 759,638 |
資産合計 | 4,254,070 | 3,580,465 |
| | (単位:千円) |
| 前事業年度 (2025年9月30日) | 当事業年度 (2026年9月30日) |
負債の部 | | |
流動負債 | | |
買掛金 | 41,074 | 56,793 |
未払金 | 77,452 | 116,331 |
未払費用 | 9,304 | 9,065 |
未払法人税等 | 10,507 | 11,892 |
預り金 | 6,969 | 6,220 |
賞与引当金 | 72,176 | 66,336 |
株式報酬引当金 | - | 1,573 |
その他 | 15,625 | - |
流動負債合計 | 233,110 | 268,213 |
固定負債 | | |
繰延税金負債 | 15,458 | - |
資産除去債務 | 162,195 | 387,113 |
株式報酬引当金 | 65,646 | 15,721 |
その他 | 88 | 963 |
固定負債合計 | 243,387 | 403,799 |
負債合計 | 476,497 | 672,012 |
純資産の部 | | |
株主資本 | | |
資本金 | 5,102,250 | 4,023,940 |
資本剰余金 | | |
資本準備金 | 3,850 | 279,978 |
資本剰余金合計 | 3,850 | 279,978 |
利益剰余金 | | |
その他利益剰余金 | | |
繰越利益剰余金 | △1,362,138 | △1,397,804 |
利益剰余金合計 | △1,362,138 | △1,397,804 |
自己株式 | △4 | △6 |
株主資本合計 | 3,743,957 | 2,906,107 |
評価・換算差額等 | | |
その他有価証券評価差額金 | 33,615 | △6,044 |
評価・換算差額等合計 | 33,615 | △6,044 |
新株予約権 | - | 8,389 |
純資産合計 | 3,777,572 | 2,908,452 |
負債純資産合計 | 4,254,070 | 3,580,465 |
E0535123700株式会社メディネットMEDINET Co., Ltd.通期第2号参考様式 [日本基準](非連結)Japan GAAPfalseCTE2025-10-012026-09-30FY2026-09-302024-10-012025-09-302025-09-301falsefalsefalse237002024-10-012025-09-30jppfs_cor:NonConsolidatedMembertse-anedjpfr-23700:ContractedCellManufacturingBusinessReportableSegmentsMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMembertse-anedjpfr-23700:CellularAndTissueBasedProductBusinessReportableSegmentsMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:ReconcilingItemsMember237002024-10-012025-09-30jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember237002024-10-012025-09-30jppfs_cor:ValuationAndTranslationAdjustmentsMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:CapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:ShareholdersEquityMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:ValuationAndTranslationAdjustmentsMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:SubscriptionRightsToSharesMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ShareholdersEquityMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalStockMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalSurplusMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:LegalCapitalSurplusMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsBroughtForwardMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationAndTranslationAdjustmentsMember237002026-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMemberjppfs_cor:NonConsolidatedMember237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:SubscriptionRightsToSharesMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ShareholdersEquityMember237002025-10-012026-09-30jppfs_cor:CapitalStockMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalSurplusMember237002025-10-012026-09-30jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:RetainedEarningsMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:RetainedEarningsBroughtForwardMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationAndTranslationAdjustmentsMember237002025-10-012026-09-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMemberjppfs_cor:NonConsolidatedMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:SubscriptionRightsToSharesMember237002026-09-30jppfs_cor:NonConsolidatedMember237002026-11-13237002025-10-012026-09-30237002026-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember237002025-10-012026-09-30jppfs_cor:TreasuryStockMemberjppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:TreasuryStockMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:ReportableSegmentsMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:ReportableSegmentsMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMembertse-anedjpfr-23700:ContractedCellManufacturingBusinessReportableSegmentsMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMembertse-anedjpfr-23700:CellularAndTissueBasedProductBusinessReportableSegmentsMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:ReconcilingItemsMember237002025-10-012026-09-30jppfs_cor:NonConsolidatedMember237002025-09-30jppfs_cor:NonConsolidatedMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMember237002024-09-30jppfs_cor:NonConsolidatedMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalStockMember237002024-09-30jppfs_cor:LegalCapitalSurplusMemberjppfs_cor:NonConsolidatedMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:CapitalSurplusMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsBroughtForwardMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:RetainedEarningsMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ShareholdersEquityMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember237002024-09-30jppfs_cor:NonConsolidatedMemberjppfs_cor:ValuationAndTranslationAdjustmentsMember237002024-10-012025-09-30jppfs_cor:NonConsolidatedMemberjpcrp_cor:UnallocatedAmountsAndEliminationMemberxbrli:pureiso4217:JPY